Lavieri AJ, Greco CF and Raco SC
With the onset of the SARS-CoV-2 pandemic, there is uncertainty about whether biological agents may place patients at increased risk of infection or a more severe disease course, either from COVID-19 or its underlying pathology. This commentary offers patient advice recommendations based on the current available evidence. Although there are currently no specific data on infected patients being treated with biologics, we present two cases, which provide information on this situation. We conclude that biological agents would not have a negative effect on this population, in the face of possible viral infection.
English 
Spanish 
Chinese 
German 
French 
Japanese 
Portuguese 
Hindi